ScholarLens Back to search
2018•Toxicology and Applied PharmacologyRequires access

H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo

Yanting Yang, Daokun Guan, Lei Lei, Jing Lu, Jia Qi Liu, Gangqiang Yang, Chunhong Yan, Rong Grace Zhai, Jingwei Tian, Yi Bi, Fenghua Fu, Hongbo Wang

Open publisher page 92 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 92 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Multiple drug resistance, Paclitaxel, P-glycoprotein, In vitro, Chemosensitizer, Pharmacology, Rhodamine 123, In vivo

Related papers

Related paper 1Related paper 2Related paper 3
Back to paper searchBrowse research topicsOriginal source
H6, a novel hederagenin derivative, reverses multidrug resistance in vitro and in vivo — Research Paper | ScholarLens